Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

TO THE EDITOR: In the article written by Veit-Haibach et al. (1), the authors highlight the growing interest in the use of radiopharmaceuticals for both diagnosis and treatment, with a significant ...

In around 20% of men with prostate cancer, metastasis develops during the course of their disease. Accordingly, discovering and developing new potent treatment strategies for patients with metastatic ...

Journal of Nuclear Medicine December 2025, jnumed.125.271365; DOI: https://doi.org/10.2967/jnumed.125.271365 ...

Journal of Nuclear Medicine December 2025, jnumed.125.270792; DOI: https://doi.org/10.2967/jnumed.125.270792 ...

The subjects of this study were those who underwent conventional wbPET imaging for clinical examination, for free medical treatment, or as part of the Japan Agency for Medical Research and Development ...

Congenital hyperinsulinism is characterized by persistent hypoglycemia due to inappropriate excess secretion of insulin resulting in hyperinsulinemic hypoglycemia. The clinical course varies from mild ...

Prostate cancer screening currently consists of serum prostate-specific antigen and digital rectal examination, followed by transrectal ultrasound-guided biopsy for diagnostic confirmation. Although ...

Quantitative 18F-FDG PET is increasingly being recognized as an important tool for diagnosis, determination of prognosis, and response monitoring in oncology. However, PET quantification with, for ...

Biochemical recurrence (BCR) after radical prostatectomy occurs in up to 40% of prostate cancer patients (1). Salvage radiotherapy (sRT) is recommended as the main curative option for patients with ...